65862-746 : Galantamine 24 mg Oral Capsule, Extended Release


NDC: 65862-746
Labeler: Aurobindo Pharma Limited
Product Type: Human Prescription Drug
Drug Name:  Galantamine
Dosage Form: Oral Capsule, Extended Release
Application #: ANDA204895
Rev. Date: 


Appearance:


Markings: A;24
Shapes:  Capsule
Colors:  Orange
Size (mm): 19
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 65862-746-01: 100 CAPSULE, EXTENDED RELEASE IN 1 BOTTLE (65862‑746‑01)
  • 65862-746-05: 500 CAPSULE, EXTENDED RELEASE IN 1 BOTTLE (65862‑746‑05)
  • 65862-746-30: 30 CAPSULE, EXTENDED RELEASE IN 1 BOTTLE (65862‑746‑30)
  • 65862-746-90: 90 CAPSULE, EXTENDED RELEASE IN 1 BOTTLE (65862‑746‑90)
  • 65862-746-99: 1000 CAPSULE, EXTENDED RELEASE IN 1 BOTTLE (65862‑746‑99)

Active Ingredients:

  • Galantamine Hydrobromide

Dosage Strength:

  • 24 mg

Inactive Ingredients:

  • Silicon Dioxide
  • Gelatin
  • Hydroxypropyl Cellulose (Type H)
  • Magnesium Stearate
  • Cellulose, Microcrystalline
  • Sodium Lauryl Sulfate
  • Talc
  • Titanium Dioxide
  • Ferric Oxide Red
  • Ferric Oxide Yellow
  • Ferrosoferric Oxide
  • Potassium Hydroxide
  • Propylene Glycol
  • Shellac
  • Ammonia

Pharmaceutical Classes:

  • Cholinesterase Inhibitor [EPC]
  • Cholinesterase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 65862-458 Galantamine 4 mg (As Galantamine Hydrobromide 5.126 mg) Oral Tablet by Aurobindo Pharma Limited
  • 65862-459 Galantamine 8 mg (As Galantamine Hydrobromide 10.253 mg) Oral Tablet by Aurobindo Pharma Limited
  • 65862-460 Galantamine 12 mg (As Galantamine Hydrobromide 15.379 mg) Oral Tablet by Aurobindo Pharma Limited
  • 65862-744 Galantamine 8 mg Oral Capsule, Extended Release by Aurobindo Pharma Limited
  • 65862-745 Galantamine 16 mg Oral Capsule, Extended Release by Aurobindo Pharma Limited
  • 0054-0090 Galantamine 4 mg Oral Tablet by West-ward Pharmaceuticals Corp.
  • 0054-0091 Galantamine 8 mg Oral Tablet by West-ward Pharmaceuticals Corp.
  • 0054-0092 Galantamine 12 mg Oral Tablet by West-ward Pharmaceuticals Corp.
  • 0378-2721 Galantamine 4 mg (As Galantamine Hydrobromide 5.126 mg) Oral Tablet by Mylan Pharmaceuticals Inc.
  • 0378-2722 Galantamine 8 mg (As Galantamine Hydrobromide 10.253 mg) Oral Tablet by Mylan Pharmaceuticals Inc.
  • 0378-2723 Galantamine 12 mg (As Galantamine Hydrobromide 15.379 mg) Oral Tablet by Mylan Pharmaceuticals Inc.
  • 0555-0138 Galantamine 4 mg (As Galantamine Hydrobromide 5.126 mg) Oral Tablet by Barr Laboratories Inc.
  • 0555-0139 Galantamine 8 mg (As Galantamine Hydrobromide 10.253 mg) Oral Tablet by Barr Laboratories Inc.
  • 0555-0140 Galantamine 12 mg (As Galantamine Hydrobromide 15.379 mg) Oral Tablet by Barr Laboratories Inc.
  • 0615-7541 Galantamine 4 mg (As Galantamine Hydrobromide 5.126 mg) Oral Tablet by Ncs Healthcare of Ky, Inc Dba Vangard Labs
  • 0615-7542 Galantamine 8 mg (As Galantamine Hydrobromide 10.253 mg) Oral Tablet by Ncs Healthcare of Ky, Inc Dba Vangard Labs
  • 0615-7543 Galantamine 12 mg (As Galantamine Hydrobromide 15.379 mg) Oral Tablet by Ncs Healthcare of Ky, Inc Dba Vangard Labs
  • 0904-7104 Galantamine 4 mg Oral Tablet, Film Coated by Major Pharmaceuticals
  • 51079-852 Galantamine 4 mg (As Galantamine Hydrobromide 5.126 mg) Oral Tablet by Mylan Institutional Inc.
  • 51079-853 Galantamine 8 mg (As Galantamine Hydrobromide 10.253 mg) Oral Tablet by Mylan Institutional Inc.
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 65862-746 QR Code

< Prev: 65862-745Next: 65862-747 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.